Thursday, July 9, 2026

biotech · CLDI

Calidi Biotherapeutics

Calidi Biotherapeutics is a biotech organization headquartered in SAN DIEGO, CA, USA. It trades on NYSE under ticker CLDI. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 7 patent record(s) to this ent

SAN DIEGO, CA, USA HQ
Public company Type
CLDI · NYSE Ticker
Company details
Status
Public
HQ
SAN DIEGO, CA, USA
Programs
0
Drugs
0
Patents
7

Quick answer

Calidi Biotherapeutics is a biotech organization headquartered in SAN DIEGO, CA, USA. It trades on NYSE under ticker CLDI. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 7 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

Company snapshot

Calidi Biotherapeutics is a biotech organization headquartered in SAN DIEGO, CA, USA. It trades on NYSE under ticker CLDI. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 7 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

  • 7 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Calidi Biotherapeutics. Not investment advice.

Momentum

Proprietary activity score for Calidi Biotherapeutics.

0 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 0 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for Calidi Biotherapeutics.

  1. Patent grant

    Smallpox vaccine for cancer treatment

  2. Patent grant

    Enhanced systems for cell-mediated oncolytic viral therapy

  3. Patent grant

    Smallpox vaccine for cancer treatment

  4. Patent grant

    Cell-based vehicles for potentiation of viral therapy

  5. Patent grant

    Combination immunotherapy approach for treatment of cancer

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Calidi Biotherapeutics?

    Calidi Biotherapeutics is a biotech organization headquartered in SAN DIEGO, CA, USA. It trades on NYSE under ticker CLDI. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 7 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sour

  • Is Calidi Biotherapeutics publicly traded?

    Yes. Calidi Biotherapeutics is listed with ticker CLDI on NYSE per SEC EDGAR records linked on this profile.

  • What drugs does Calidi Biotherapeutics develop or market?

    No drug profiles are currently linked to Calidi Biotherapeutics. Pipeline programs may still list investigational assets.

  • What are the latest developments for Calidi Biotherapeutics?

    Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

  • What therapeutic areas does Calidi Biotherapeutics focus on?

    No specific therapeutic focus areas are currently identified for Calidi Biotherapeutics in our database.

Therapeutic focus